A CASE FOR THE TRIPS VACCINE WAIVER
Updated: 3 days ago
This post is authored by Esha Goyal, a fourth-year student of B.A. LL.B. (Hons.) at National Law School of India University, Bangalore.
Image Credits: Reuters
On May 21, 2021, in the wake of the concerted global effort to tackle the COVID-19 pandemic, a group of developing and least developed countries - led by South Africa and India - proposed revised waivers from the patent requirements in the World Trade Organisation ("WTO") Agreement on Trade-Related Aspects of Intellectual Property Rights ("TRIPS Agreement") to increase vaccine production and ensure equitable supply. These measures have been met with stiff resistance from developed